Home
PHARMACEUTICAL COMPANY FOCUSED ON CANNABIS FOR THE BETTERMENT OF MANKIND
PHARMACEUTICAL COMPANY FOCUSED ON CANNABIS FOR THE BETTERMENT OF MANKIND
Mandara Pharma is deeply committed to delivering safe, effective, high-quality products for consumers by meeting the highest pharmaceutical standards for cannabinoid-based products.
Mandara Pharma combines novel technology platforms with targeted cannabis genetics.
Pharmaceutical Heritage - Our Unique Strength
Genetics & Cultivation
Our expertise in genetics positions Mandara Pharma for dramatic growth and builds our value.
We own a broad range of 213 high-/low-producing CBD and THC strains developed in our genetics labs in Colombia and Spain and registered in Colombia.
Ten of the CBD-dominant strains have received PEAs registration in Colombia allowing them to be cultivated, extracted, and transported for international use.
This ownership is unique in the industry and enables us to create any customized strain we require.
Product Development
Once a cannabinoid profile has been matched to a disease or condition and the strains have been registered, the product development process begins.
- Analytical characterization to verify the cannabinoid profile
- Formulation development including specialized delivery systems
- Non-clinical studies in animals
- Clinical trials in humans – Phase I to III
- Regulatory submission
Quality, Manufacturing, Compliance
At Mandara Pharma, we promote a culture of Quality across all of our activities.
From seed to sale, Mandara Pharma operations are carried out under a strict quality control system.
Commercialization
Our senior leadership has extensive experience in bringing pharmaceutical products from conception through production to market.
- Sell or license our drug products (clinical trial-based) to global pharmaceutical companies.
- Sell or license our API to pharma companies and R&D companies and they will conduct clinical trials and bring the new therapies to market.
- Well-positioned to be an international supplier of high-quality medical-grade products.
Global Operations
-
USA
Mandara Pharma Inc. has entered into a strategic partnership with MandaraRx (formerly known as BoomRx), a cannabis sales and distribution company headquartered in Boulder, Colorado.
-
Colombia
Through Mandara Pharma Colombia S.A.S. and strategic alliances, genetics, cultivation, GMP extraction and R&D programs are in operation in Roldanillo, Valle del Cauca and the Latin American headquarters in Cali.
Fully-licensed cultivation capacity of 1.9M sq. ft. in Colombia – ideal climate and growing conditions at very low cost.
-
Spain
Through Mandara Pharma Spain S.L., a European corporate office has been established in Parc Scientific, University Politechnical of Valencia (UPV) to develop genetic strains and development of in-vitro tissue culture and micropropagation techniques.
-
Canada
Mandarapharma Inc. is a registered company in Ontario, Canada. It specializes in the cannabis-based pharmaceutical industry, holding licenses in Colombia for the cultivation, extraction, transformation, transport and export of both psychoactive and non-psychoactive cannabis plants.
Our global footprint helps us develop pharmaceutical-grade cannabis extractions, while encouraging social entrepreneurship that benefits the communities where we work.
About Us
Reach Out To Us
Learn how we set the standards for cannabis-based pharmaceutical industry. For more information about investment opportunities, please contact us. We want to meet you.
Mandara Pharma is committed to cultivating Nature’s nurturing plant for the betterment of mankind.
Connect